Hepatitis B Virus Infection and MicroRNAs: Future Trends to Diagnostics and Therapeutics
Hepatitis B virus (HBV) infects the liver and causes acute and chronic sickness, which can progress to severe end-stage liver disease. Despite the availability of an effective vaccination and a variety of treatment options, this virus remains the leading cause of liver disease, accounting for a significant portion of...
Read More
Study on Herbal Medicines, Ascorbic Acid, Cyanocobalamin, Tenofovir, Treatment on HBeAg Positive or HBeAg Negative in Chronic Hepatitis B: A Combination of Treatment with Herbs
The World Health Assembly in 2016 called for the global eradication of viral hepatitis by 2030, setting global goals of a 90 percent reduction in new cases of hepatitis B and C, a 65 percent reduction in hepatitis B and hepatitis C deaths, and treatment of 80 percent of...
Read More
A Critical Study of Hepatitis B Virus Genotypes and Mutation in 1762 & 1764 Nucleotides of X Gene in Chronic HBV Patients from Golestan Province—Iran
Around 378 million individuals are estimated by the WHO to be chronic carriers of HBV and many of them develop progressive diseases, including cirrhosis and hepatocellular carcinoma. Genetic variants have been suggested to be associated with an increased risk of hepatocellular carcinoma caused by fulminant hepatitis B. The purpose...
Read More